Mutational Spectrum, Copy Number Changes, and Outcome: Results of a Sequencing Study of Patients With Newly Diagnosed MyelomaBrian A. Walker, Gareth J. Morgan, Martin Kaiser et al.|Journal of Clinical Oncology|2015Cited by 564
Chronic Lymphocytic Leukemia Therapy Guided by Measurable Residual DiseaseTalha Munir, Peter Hillmen, David A. Cairns et al.|New England Journal of Medicine|2023Cited by 155
miR-17-92 fine-tunes MYC expression and function to ensure optimal B cell lymphoma growthMarija Mihailovich, Tiziana Bonaldi, Michael Bremang et al.|Nature Communications|2015Cited by 107
Measurable Residual Disease–Guided Therapy for Chronic Lymphocytic LeukemiaTalha Munir, Peter Hillmen, Sean Girvan et al.|New England Journal of Medicine|2025Cited by 26